Aqua Pharma is a leading veterinary services provider for the aquaculture industry. We design and develop solutions for fish and shrimp health globally. We operate in eight countries, with around 50 employees across the world.
The main market for Aqua Pharma is salmon farming but we also develop treatment solutions for other species, from shrimp to kingfish, trout, seabass and seabream.
Aqua Pharma goes beyond basic expectations and continuously improves in prevention and control methods, where technology allows it.
We contribute to maintaining a responsible aquaculture industry by going beyond basic expectations. By evolving our systems, we support the Aquaculture producers in meeting their objectives.
Our vision “What it Takes” reﬂects our employees’ attitude in their daily work and is the inspiration behind all our activities. Aqua Pharma always goes beyond the customer’s expectations, bringing innovative thinking to old problems. We promote quality and take pride in the work we do. We are committed to our team and our customers and constantly work towards safe and sustainable approaches for management of life below water.
First salmon farming in Norway (Pens in the sea)
Still a relatively young business, aquaculture started with salmon and trout in the late 1980s. As the industry developed, investors sought to boost production by increasing the density of fish grown in cages. The more fish, however, the more rapid the spread of disease, which affects their health and growth if left untreated. Salmon production loses some $1 billion a year due to sea lice so there is a pressing need to ensure the health and viability of the fish we eat.
Aquatiq Norway – experts in food safety – enter the scene, setting up Aqua Pharma. They developed a concept for safe and sustainable bath treatments for both tarpaulin and well boat treatments. Solvay supported product knowledge.
Other countries quickly follow, with operations set up in all the main salmon farming countries.
In September 2019, a joint venture between Aquatiq and Solvay is created, and Aqua Pharma becomes Aqua Pharma Group. The joint venture will accelerate research initiatives and support the further growth of Aqua Pharma Group in new markets.
Interested in knowing how it all started ?
Aqua Pharma Group employs over 50 people in 8 different countries.